Bacterial Meningitis A Case presentation for the requirement of Internal Medicine Residency Training
1.
“Brain under Siege:
TheDangers of
Traumatic Brain
infections”
Dr. Don Jayric V. Depalobos
2nd
Year Internal Medicine Resident
Ospital Ng Palawan
Subspecialty Conference on Infectious Diseases
2.
OBJECTIVES
To present acase of a 21/M who was brought due
to upward rolling of eyeballs and stiffening of
extremities with associated headache, and fever
To discuss approach to patient presenting with
upward rolling of eyeballs and stiffening of
extremities with associated headache, and fever
To Identify treatment and management
algorithms for patients with the said condition
3.
CASE PRESENTATION
01
COURSE INTHE WARD
02
DISCUSSION AND
CONCETP MAP
03
ASSESSMENT AND
DIFFERENTIAL
DIAGNOSIS
04
TAKE AWAY
05
REFERENCES
06
TABLE OF CONTENTS
HISTORY OF PRESENTILLNESS
(+)
Increasing
severity of
headache
(+) Fever
(+)Decrease
d sensorium
(+)headache
Sought consult at BDH
Started Ceftriaxone 2gm IV
Mannitol 100cc IV
Paracetamol 600mg IV
(+) Stiffening of
extremities and
upward rolling of
eyeballs
No consult done.
No meds taken.
3 days
pta
1 day
pta
Few
hours
pta
6.
Past Medical
History
(+) MVAOct 2024
sustained frontal
bone fracture
(+) Primary Complex
Personal/
Social History
2.5 pack year smoker
Occasional Alcoholic
Beverage drinker
Family Medical
History
(+)HPN – Both sides
Vaccination History
(+) COVID Vaccination
Childhood vaccination
was given but
unrecalled if completed
A
C
B
D
7.
PHYSICAL EXAMINATION
Vital Signs:Vital Signs: BP 110/80 HR 65 RR 22 T 37.8 C
Spo2 95% at 2lpm NC
General Status: Awake, GCS 9 (E2V2M5), in mild
respiratory distress. Confused, weak-looking.
Head and Neck: (+) Nuchal Rigidity, (+) Kernig’s Sign,
(-) Brudzinski Sign; No visible or palpable masses,
depressions, or scarring. Hair is of normal texture and evenly
distributed. No neck vein distention
Non-erythematous, not enlarged tonsils
EENT: (+) Preferential Gaze (Right); (+) Horizontal
nystagmus; pink conjunctivae, Anicteric, Pink Palpebral
Conjunctiva, No CLAD, No nystagmus
Pupils equally reactive to light at 5mm, OU
Fundoscopy: No papilledema
8.
PHYSICAL EXAMINATION
Chest andLungs:
Symmetrical Chest Wall Expansion, Clear Breath Sounds
Cardiac: External chest is normal in appearance without lifts,
heaves, or thrills. PMI is not visible and is palpated in the 5th
intercostal space at the midclavicular line. Normal rate with normal
rhythm. No murmurs, gallops, or rubs are auscultated.
Abdomen: There are no visible lesions or scars. Umbilicus is
normal without herniation. Bowel sounds are present and
normoactive. Soft, symmetric, and non-tender without distention. No
masses, hepatomegaly, or splenomegaly are noted.
9.
PHYSICAL EXAMINATION
Genitourinary: nomasses or lesions noted.
Skin and Extremities: No gross deformities noted on upper and lower
extremities. Good and equal pulses, no tremors, no limitations on range
of motions noted. Nails without wounds or lesions, Capillary refill time of
<2s.
Neurologic: CN are intact. No Brudzinski. (+) Kernig. (+) Nuchal
Rigidity
10.
PHYSICAL EXAMINATION
Constitutional: generalizedbody malaise, (+)fever
HEENT: No sore throat
Skin: No caput medusae. No telangiectasia. (+) Bruises on IV
insertion and injection sites
Cardiovascular: (-)Palpitations, (-)Easy Fatigability
Respiratory: Shortness of breath
Gastrointestinal: no changes in bowel movement
Genitourinary: no dysuria, flank pains, change in urination
Neurologic: no sensory deficits or motor deficits
11.
Initial Impression
CNS Infectionprobably Bacterial
secondary to Multiple Skull Fracture
secondary to Motor Vehicular
Accident;
Rule Out Brain Abscess
12.
Patient J.G. 21/M
HEADACHEFEVER
NUCHAL
RIGIDITY and
KERNIG’S SIGN
HISTORY OF
TRAUMA
SEIZURES
SENSORIUM
CHANGES
Admission Day (ER)
(February6, 2025)
Subjective Objective Assessment Plan
Headache 9/10
Changes in behavior
Awake
GCS 9 (E2V2M5)
Vital Signs:
BP 120/90
HR 82
RR 20
T 38
Spo2 99% at 3lpm
Pupils equally reactive to light at
5mm, OU
Preferential gaze
Nuchal Rigidity
SCWE CBS
AP NRRR
Soft nontender abdomen
FEP no edema <2s CRT
CNS Infection probably
Bacterial secondary to
Multiple Skull Fracture
secondary to Motor Vehicular
Accident;
Rule Out Brain Abscess;
MVA Self crash with Multiple
Skull Fracture Oct 2024
Diet: OF 1,400 kcal in 6 divided feedings
IVF: PNSS 1L x 100cc/hour
Diagnostics:
RBS CBC Na K Crea BUN,
Chest Xray, Cranial Ct Scan with Contrast
12 Lead ECG, UA
Plain Cranial CT Scan was done outside
Therapeutics:
Ceftriaxone 2gm IV q12
Mannitol 100cc IV q6
Diazepam 5mg IV PRN for frank seizures
Paracetamol 300mg IV q4 PRN
O2 at 2-3lpm via NC
IFC Inserted
NGT Inserted
Vital Signs q2
Neuro Vital Signs q2
I&O q shift
18.
Admission Day (WARD)
(February7, 2025)
Subjective Objective Assessment Plan
Headache 9/10
Changes in behavior
Awake
GCS 9 (E2V2M5)
Vital Signs:
BP 110/80
HR 65
RR 22
T 37.8
Spo2 95% at 3lpm
Pupils equally reactive to light at
5mm, OU
Preferential gaze
Nuchal Rigidity
SCWE CBS
AP NRRR
Soft nontender abdomen
FEP no edema <2s CRT
CNS Infection probably
Bacterial secondary to
Multiple Skull Fracture
secondary to Motor Vehicular
Accident;
Rule Out Brain Abscess;
MVA Self crash with Multiple
Skull Fracture Oct 2024
Diet: OF 1,400 kcal in 6 divided feedings
IVF: PNSS 1L x 100cc/hour
Additional Diagnostics:
Blood Culture x 2 sites
Procalcitonin
iCa, Mg, FBS CBG q6
CSF Analysis/Lumbar Tap
Contrast-enhanced Cranial CT Scan
Therapeutics:
Vancomycin 1gm + 100cc PNSS IV to run for 4
hours q12
Dexamethasone 10mg IV q6 x 4 days
Omeprazole 40mg IV q12
Father apprised of Pt’s condition and
prognosis
Referred to IDS Service
LDH, BSMP, Dengue Duo, ABG
CSF Fluid Gene Xpert
Skull Xray PA2/7/25
Findings:
A depressed fracture is seen involving the
midline frontal bones with overlying soft
tissue swelling. The rest of the calvarium is
normal with symmetrical appearance.
Impression:
Depressed Fracture is seen involving the
midline frontal
Chest Xray PA 2/7/25
Findings:
Bilateral Hilar fullness with accentuation of bronchovascular
markings is noted.
The rest of the lungs show no active parenchymal opacities.
The heart is not enlarged.
The diaphragm, sulci, and bony thorax are intact.
Impression:
Signs of Pulmonary Congestion. Intercurrent Pneumonia is not
ruled out.
21.
12 Lead ECG02/06/2025
Rate 65 Regular Sinus Rhythm
No Chamber enlargement
No axis deviation
Normal Sinus Rhythm
02/13
CSF Gene Xpert
(2/12/25)
MTBnot detected
Gram Stain (02/08/25) Organism: Gram
(+) Cocci in Singles
– Rare
Epithelial: 0-1/LPO
Pus Cells: 0-1/HPO
Blood and SCF
Culture
No Growth
CSF Cell Count WBC 0.80 cells/cu
mm
CSF Differential
Count
PMN 56%
MNC 44%
ABG 2/8/25
pH 7.56
CO2 18.5
O2 126.2
HCO3 17
Partially
Compensated
Respiratory
Alkalosis with
Overcorrected
OXygenation
24.
Hospital Day 1-3
(February8-10, 2025)
Subjective Objective Assessment Plan
On/Off Headache 9/10
Changes in behavior
(+)Nausea
Ceftriaxone Day 3
Vancomycin Day 3
Awake
GCS 14 (E4V4M6)
Vital Signs:
BP 110/60
HR 63
RR 22
T 36.1
Spo2 98% at 3lpm
Pupils equally reactive to light at
5mm, OU
Preferential gaze
Nuchal Rigidity
SCWE CBS
AP NRRR
Soft nontender abdomen
FEP no edema <2s CRT
iCa 0.84
Fundoscopy: pale pink 1.5mm
disk with sharp flat margin. Cup
is within the disk. Vessels are
enlarged and prominent
CNS Infection probably
Bacterial secondary to
Multiple Skull Fracture
secondary to Motor Vehicular
Accident;
Rule Out Brain Abscess;
MVA Self crash with Multiple
Skull Fracture Oct 2024;
Hypocalcemia
Calcium Gluconate 10ml SIVP now
Nimodipine 30mg tab 2 tabs q4
Metoclopramide 10mg SIVP q8 PRN
Lumbar Tap was done
IDS Rounds:
Increase Mannitol to 150cc q4
For repeat Procalcitonin
Hospital Day 5-7
(February11-14, 2025)
Subjective Objective Assessment Plan
No nuchal Rigidity
No Headache
No fever
Ceftriaxone Day 4
Vancomycin Day 4
Awake
GCS 15 (E4V5M6)
Vital Signs:
BP 120/70
HR 58
RR 220
T 36.5
Spo2 98% at room air
Pupils equally reactive to light at
5mm, OU
SCWE CBS
AP NRRR
Soft nontender abdomen
FEP no edema <2s CRT
Procalcitonin
7.159 from 45
Bacterial Meningitis
secondary to Multiple Skull
Fracture secondary to Motor
Vehicular Accident;
Rule Out Brain Abscess;
MVA Self crash with Multiple
Skull Fracture Oct 2024
Titrate down Mannitol
To Complete Antibiotics to 10 days
27.
Hospital Day 8-12
(February15-18, 2025)
Subjective Objective Assessment Plan
No nuchal Rigidity
No Headache
No fever
Ceftriaxone Day 10
Vancomycin Day 10
Awake
GCS 15 (E4V5M6)
Vital Signs:
BP 100/60
HR 67
RR 21
T 36.7
Spo2 98% at room air
Pupils equally reactive to light at
5mm, OU
SCWE CBS
AP NRRR
Soft nontender abdomen
FEP no edema <2s CRT
Procalcitonin
0.77 from 7,159
CNS Infection probably
Bacterial secondary to
Multiple Skull Fracture
secondary to Motor Vehicular
Accident;
Rule Out Brain Abscess;
MVA Self crash with Multiple
Skull Fracture Oct 2024
Titrate down Mannitol
To Complete Antibiotics to 10 days
Patient was then sent home Improved
Home Meds:
Clindamycin
Bacterial Meningitis
Bacterial meningitisis an acute purulent
infection within the sub- arachnoid
space (SAS).
It is associated with a CNS inflammatory
reaction that may result in decreased
consciousness, seizures, raised
intracranial pressure (ICP), and stroke.
The meninges, SAS, and brain
parenchyma are all frequently involved
in the inflammatory reaction
(meningoencephalitis).
Harrison’s Principles of Internal Medicine 21st
Edit
31.
Bacterial meningitis isthe most common form of
suppurative CNS infection, with an annual incidence in
the United States of >2.5 cases/100,000 population.
• Streptococcus pneumoniae (~50%)
• Neisseria meningitidis (~25%)
• Group B streptococci (~15%)
• Listeria monocytogenes (~10%)
• Haemophilus influenzae type b accounts for <10% of
cases of bacterial meningitis in most series.
• N. meningitidis is the causative organism of
recurring epidemics of men- ingitis every 8–12
years.
Epidemiology
Harrison’s Principles of Internal Medicine 21st
Edit
32.
In 1999, theCNS Infection
Council of the Philippine
Neurological Association did a
study to determine the
spectrum of CNS infections
seen in this country by
combining the census of all the
neurology training institutions.
Epidemiology
The PCP Textbook of Internal Medicine 1st
Edition
33.
1. Bacterial orPyogenic
2. Tuberculous
3. Viral
4. Fungal (mostly cryptococcal)
A. Acute - Less than a week
B. Sub-Acute – 1-2 weeks
C. Chronic – More then 2 weeks
Major Types of Meningitis
The PCP Textbook of Internal Medicine 1st
Edition
34.
Approach to SuspectedMeningitis
1. Is this Meningitis or Encephalitis?
Meningitis - fever, headache, neck rigidity, no focal signs,
relative preservation of mentation or consciousness.
"Patient can relate to you his history" (Proceed to #2)
Encephalitis - fever + (mental, behavioral or sensorial
change), the latter occurring at the onset of the illness,
acute course (Proceed to # 4)
35.
Approach to SuspectedMeningitis
2. If this is a meningitic syndrome, classify according to
acute, subacute, or chronic.
Acute: < 1 week course
Subacute: 1 to 2 weeks
Chronic: > 2 weeks
36.
Approach to SuspectedMeningitis
3. What major type of meningitis would it likely be?
If acute - bacterial or viral
If chronic - TB or fungal If subacute - consider
all 4
37.
Approach to SuspectedMeningitis
4. Look for the following before doing
an LP - focal signs, papilledema,
signs of herniation.
38.
Approach to SuspectedMeningitis
Recommended criteria for adult patients with suspected
bacterial meningitis who should undergo CT prior to lumbar
puncture
39.
Approach to SuspectedMeningitis
5. If any of the above are present, do first a CT scan or
MRI to rule out a mass lesion.
If none of the above are present, proceed with an LP.
6. If a mass lesion (e.g., abscess, tumor) is seen
on neuroimaging, treat accordingly.
Don't do a tap.
7. If no mass lesion is seen on CT or MRI,
proceed with LP.
40.
Approach to SuspectedMeningitis
8. Lumbar puncture:
Measure opening pressure. If > 300 mm H,0, run Mannitol first until pressure drops to
at 300 mmH2O before withdrawing fluid.
For adults, take 10 cc or more divided as follows:
1st bottle - 2 cc for protein and glucose
2nd bottle - 7 cc for microbiological studies. Reserve for Cryptococcal antigen latex
agglutination test (CALAS) and other studies. To the sediment, do G/S, C/S, India ink
smear, Saboraud's culture, TB culture.
3rd bottle - 1 cc - cell count with differential
4th bottle - 1 cc or more - for other studies as indicated by clinical suspicion (e.g., PCR
for herpes, biofilm array for meningitis-en-cephalitis panel, etc)
CSF lactate concentrations of >4.2 mmol/L were considered to be a positive
discriminative factor for bacterial meningitis
41.
Approach to SuspectedMeningitis
9. Look at the routine CSF picture (WBC, differential, sugar,
protein) to determine major type of meningitis one (bacterial,
TB or fungal, viral)
42.
Approach to Suspected
Meningitis
10.If stains are positive, treat accordingly.
Correlate with CSF picture.
G/S: (+ ) for bacteria - start empiric treatment.
India ink smear: round to oval organisms with a
double refractile wall - treat for Cryptococcus.
A (+) AFB smear from the CSP is extremely rare
in the Philippine setting.
43.
Approach to SuspectedMeningitis
On the basis of the available evidence on the use of adjunctive
dexamethasone in adults, we recommend use of dexamethasone (0.15
mg/kg q6h for 2–4 days with the first dose administered 10–20 min before, or
at least concomitant with, the first dose of antimicrobial therapy) in adults
with suspected or proven pneumococcal meningitis (A-I).
Infectious Disease Society of America (IDSA)
44.
Approach to SuspectedMeningitis
11. If CS picture is compatible with bacterial meningitis, and the
stains are negative, treat empirically for bacterial meningitis.
12. If stains are negative, and CSF picture is compatible with
TB or fungal meningitis, presume TB and treat as such.
13. If cryptococcal antigen latex agglutination system (CALAS) is (+), but India ink
is (-) for cryptococcus, repeat tap the next day for India ink and CALAS because
the test has a 10% false positivity rate.
If CALAS is again (+) and India ink remains negative, one can treat presumptively
as cryptococcal meningitis.
If CALAS is negative, cryptococcal meningitis can virtually be ruled out (CALAS
negative predictive value is 100% by the local validation study of the author), so
long as the India ink stain and culture are negative.
45.
Approach to SuspectedMeningitis
14. When cultures show an isolate (bacteria, TB, cryptococcus), treat accordingly
using drugs specific for the isolated etiologic organism and guided by sensitivity
results.
Approach to SuspectedMeningitis
15. If clinical and CS picture is compatible with viral meningitis,
treat symptomatically.
16. If clinical diagnosis is ENCEPHALITIS the main task is to
determine if this is HERPES SIMPLEX OR NON-HERPES
SIMPLEX, because only the former (and possibly Varicella-
zoster and Epstein-Barr) have been proven to be treatable.
48.
Approach to SuspectedMeningitis
17. Do LP for CSF analysis as for meningitis, but reserve at least 1 cc for Polymerase
Chain Reaction (PCR) or biofilm array meningitis/ encephalitis panel for herpes and
other viruses.
18. EEG, CT and MRI should be done as quickly as possible to detect focal
abnormalities in the fronto-temporal lobes, which support a diagnosis of herpes
simplex.
a. EEG - periodic sharps or spikes from one or both frontal and/or temporal lobes.
b. CT / MRI - focal abnormalities at the frontal, temporal or cingulate areas (MRI is
more sensitive than CT).
49.
Approach to SuspectedMeningitis
19. If routine CS picture is compatible with a viral encephalitis and/or EEG and
neuroimaging is/are suggestive of herpes, start presumptive treatment for herpes with
IV acyclovir.
20. If PCR for herpes turns out negative, discontinue acyclovir unless zoster or EBV
encephalitis is suspected, or EEG, CT or MRI shows focal abnormalities suggestive
of herpes. Continuing with acyclovir therapy for herpes is an option despite absence
of evidence for herpes if the clinician believes or wants to give the patient the
potential benefit of acyclovir treatment.
21. For CMV-related CNS infections, ganciclovir and foscarnet may be tried.
22. For California encephalitis, adenovirus, rotavirus, LCMV and other arenavirus
encephalitis: may try IV rivabirin.
50.
Diagnosis of BacterialMeningitis
The classic CSF abnormalities in bacterial meningitis are:
(1) Polymorphonuclear (PMN) leukocytosis (>100 cells/μL in 90%)
(2) Decreased glucose concentration (<2.2 mmol/L [<40 mg/dL] and/or
CSF/serum glucose ratio of <0.4 in ~60%)
(3) Increased protein concentration (>0.45 g/L [>45 mg/dL] in 90%),
(4) Increased opening pressure (>180 mmH2O in 90%).
CSF bacterial cultures are positive in >70% of patients, and CSF
Gram’s stain demonstrates organisms in >60%.
Increased Intracranial Pressure
Emergencytreatment of increased ICP includes elevation of the
patient’s head to 30–45°, intubation, and hyperventilation (PaCO2
25–30 mmHg), and mannitol. Patients with increased ICP should be
managed in an intensive care unit; accurate ICP measurements are
best obtained with an ICP monitoring device.
PROGNOSIS
Mortality Rate forBacterial Meningitis:
3–7% for meningitis caused by H. influenzae, N. meningitidis, or group B streptococci;
15% for that due to L. monocytogenes;
20% for S. pneumoniae.
In general, the risk of death from bacterial meningitis increases with (1) decreased level
of consciousness on admission
(2) onset of seizures within 24 h of admission
(3) signs of increased ICP
(4) young age (infancy) and age >50
(5) the presence of comorbid conditions including shock and/or the need for
mechanical ventilation,
(6) delay in the initiation of treatment.
Decreased CSF glucose concentration (<2.2 mmol/L [<40 mg/dL]) and markedly
increased CSF protein concentration (>3 g/L [> 300 mg/dL]) have been predictive of
increased mortality and poorer outcomes in some series. Moderate or severe sequelae
TAKE AWAY…
• Meningitisis a devastating disease with a high case fatality rate,
which can lead to serious long-term complications (sequelae).
• Meningitis remains a major global public-health challenge.
• Many organisms can cause meningitis, including bacteria,
viruses, fungi and parasites.
• Bacterial meningitis is of particular concern. Around 1 in 6 people
who get this type of meningitis die and 1 in 5 have severe
complications.
• Safe affordable vaccines are the most effective way to deliver
long-lasting protection.